Preparation and evaluation of a novel delayed-onset sustained-release system of propranolol hydrochloride

Journal of Pharmacy and Pharmacology

Volumn 60, Issue 7, 2008, Pages 817-822

  Feng, Xue Mei ^a,b   Ren, Qi ^b   Zhang, Wen Zhi ^c   Shen, Hui Feng ^b   Rong, Zheng Xing ^a   Fang, Chao ^a   Chen, Hong Zhuan ^a,d  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Polymer Pharmaceutical and Excipient Co Ltd   (China)

^c SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^d SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ETHYL CELLULOSE; EUDRAGIT; HYDROXYPROPYLMETHYLCELLULOSE; PROPRANOLOL;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CHRONOTHERAPY; DELAYED ONSET SUSTAINED RELEASE FORMULATION; DOG; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG COATING; DRUG DOSAGE FORM COMPARISON; DRUG ELIMINATION; DRUG SOLUBILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; SUSTAINED RELEASE CORE TABLET; SUSTAINED RELEASE FORMULATION; TABLET FORMULATION; TIME;

ANIMALS; DELAYED-ACTION PREPARATIONS; DOGS; MALE; PROPRANOLOL; SOLUBILITY; TABLETS;

EID: 46249089826     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/jpp.60.7.0002     Document Type: Article

References (29)

1. Badve, S. S., Sher, P., Korde, A., Pawar, A. P. (2007) Development of hollow/porous calcium pectinate beads for floating-pulsatile drug delivery. Eur. J. Pharm. Biopharm. 65: 85-93
2. Barzegar-Jalali, M., Adibkia, K., Mohammadi, G., Zeraati, M., Bolagh, B. A., Nokhodchi, A. (2007) Propranolol hydrochloride osmotic capsule with controlled onset of release. Drug Deliv. 14: 461-468
3. Cao, Q. R., Choi, H. G., Kim, D. C., Lee, B. J. (2004) Release behavior and photo-image of nifedipine tablet coated with high viscosity grade hydroxypropylmethylcellulose: effect of coating conditions. Int. J. Pharm. 274: 107-117
4. Carter, B. L. (1998) Optimizing delivery systems to tailor pharmaco-therapy to cardiovascular circadian events. Am. J. Health Syst. Pharm. 55 (Suppl. 3): S17-S23
5. Gazzaniga, A., Iamartino, P., Maffione, G., Sangalli, M. E. (1994) Oral delayed-release system for colonic specific delivery. Int. J. Pharm. 108: 77-83
6. Goldbete, A., Claude, D. (2002) Time-patterned drug administration: insights from a modeling approach. Chronobiol. Int. 19: 157-175
7. Goole, J., Vanderbist, F., Amighi, K. (2007) Development and evaluation of new multiple-unit levodopa sustained-release floating dosage forms. Int. J. Pharm. 334: 35-41
8. Haider, A., Sa, B. (2006) Sustained release of propranolol hydro-chloride based on ion-exchange resin entrapped within polystyrene microcapsules. J. Microencapsul. 23: 899-911
9. Kamba, M., Seta, Y., Kusai, A., Nishimura, K. (2002) Comparison of the mechanical destructive force in the small intestine of dog and human. Int. J. Pharm. 237: 139-149
10. Katori, N., Aoyagi, N., Terao, T. (1995) Estimation of agitation intensity in the GI tract in humans and dogs based on in vitro/in vivo correlation. Pharm. Res. 12: 237-243
11. Kim, H. K., Hong, J. H., Park, M. S., Kang, J. S., Lee, M. H. (2001) Determination of propranolol concentration in small volume of rat plasma by HPLC with fluorometric detection. Biomed. Chroma-togr. 15: 539-545
12. Lemmer, B. (2004) Circadian rhythms and clinical pharmacology. Internist (Bed) 45: 1006-1020
13. Lemmer, B. (2005) Chronopharmacology and controlled drug release. Expert Opin. Drug Deliv. 2: 667-681
14. Lemmer, B. (2006) The importance of circadian rhythms on drug response in hypertension and coronary heart disease-from mice and man. Pharmacol. Ther. 111: 629-651
15. Lin, S. Y., Lin, K. H., Li, M. J. (2001) Micronized ethylcellulose used for designing a directly compressed time-controlled disintegration tablet. J. Control. Release 70: 321-328
16. McConville, J. T., Ross, A. C., Florence, A. J., Stevens, H. N. (2005) Erosion characteristics of an erodible tablet incorporated in a time-delayed capsule device. Drug Dev. Ind. Pharm. 31: 79-89
17. Mohamad, A., Dashevsky, A. (2006) Development of pulsatile mul-tiparticulate drug delivery system coated with aqueous dispersion Aquacoat ECD. Int. J. Pharm. 318: 124-131
18. Mohammadi-Samani, S., Adrangui, M., Siahi-Shadbad, M. R., Nokhodchi, A. (2000) An approach to controlled-release dosage form of propranolol hydrochloride. Drug Dev. Ind. Pharm. 26: 91-94
19. Ning, Z., Jiabi, Z. (2002) Preparation of diltiazem hydrochloride delayed-onset sustained release tablet. Acta Pharmaceutica Sinica 37: 724-727
20. Noble, R. E. (2003) Drug therapy in the elderly. Metabolism 52: 27-30
21. Phaechamud, T., Ritthidej, G. C. (2007) Sustained-release from layered matrix system comprising chitosan and xanthan gum. Drug Dev. Ind. Pharm. 33: 595-605
22. Ross, A. C., MacRae, R. J., Walther, M., Stevens, H. N. (2000) Chronopharmaceutical drug delivery from a pulsatile capsule device based on programmable erosion. J. Pharm. Pharmacol. 52: 903-909
23. Sawada, T., Kondo, H., Nakashima, H., Sako, K., Hayashi, M. (2004) Time-release compression-coated core tablet containing nifedipine for chronopharmacotherapy. Int. J. Pharm. 280: 103-111
24. Schwartz, J. B. (2003) The influence of sex on pharmacokinetics. Clin. Pharmacokinet. 42: 107-121
25. Sica, D., Frishman, W. H., Manowitz, N. (2003) Pharmacokinetics of propranolol after single and multiple dosing with sustained release propranolol or propranolol CR (innopran XL), a new chronotherapeutic formulation. Heart Dis. 5: 176-181
26. Tam, Y. K. (1993) Individual variation in first-pass metabolism. Clin. Pharmacokinet. 25: 300-328
27. Verma, R. K., Garg, S. (2004) Development and evaluation of osmotically controlled oral drug delivery system of glipizide. Eur. J. Pharm. Biopharm. 57: 513-525
28. White, W. B. (2001) Cardiovascular risk and therapeutic intervention for the early morning surge in blood pressure and heart rate. Blood Press. Monit. 6: 63-72
29. Zou, H., Jiang, X., Kong, L., Gao, S. (2008) Design and evaluation of a dry coated drug delivery system with floating-pulsatile release. J. Pharm. Sci. 97: 263-273